Revance pivots into therapeutics with cervical dystonia nod for Botox rival Daxxify fkansteiner Mon, 08/14/2023 – 13:53 More: Revance pivots into therapeutics with cervical dystonia nod for Botox rival Daxxify Source: fierce
read moreGeneFab debuts as manufacturer, acquires Senti Bio’s production tech for $38M jkeenan Mon, 08/14/2023 – 12:26 More: GeneFab debuts as manufacturer, acquires Senti Bio's production tech for M Source: fierce
read moreChasing AstraZeneca and Pfizer, Johnson & Johnson snags FDA nod for prostate cancer combo Akeega kdunleavy Mon, 08/14/2023 – 11:15 More: Chasing AstraZeneca and Pfizer, Johnson & Johnson snags FDA nod for prostate cancer combo Akeega Source: fierce
read morePfizer attempts to ward off generic competition to pricey heart med Vyndamax with patent lawsuit zbecker Mon, 08/14/2023 – 11:13 More: Pfizer attempts to ward off generic competition to pricey heart med Vyndamax with patent lawsuit Source: fierce
read moreArcturus JV scored $115M in Japanese grants to boost mRNA manufacturing aliu Mon, 08/14/2023 – 11:07 More: Arcturus JV scored 5M in Japanese grants to boost mRNA manufacturing Source: fierce
read moreIDEAL study aims to determine the impact of seladelpar on alkaline phosphatase levels More: CymaBay begins phase 3 liver disease study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals